The purpose of the subsidiary is to support the Company’s Japanese clinical and radiopharmaceutical manufacturing activities and to establish a commercial footprint in the Japan, an important market for Telix’s…
Glaxo announced today it has received approval from the FDA's Center for Biologics Evaluation and Research expanding the indication for FLUARIX to include use in persons 6 months and older.…
A look at 6 up and coming blood-testing startups. Source: BioSpace
The EU approval is based on data from three pivotal Phase III studies from the ORCHESTRA trial programme of 2,388 patients who met primary and nearly all key secondary endpoints.…
During the J.P. Morgan Healthcare Conference, Sage provided an update on its long-term strategy to drive growth at the company. Source: BioSpace
Y Combinator is launching an accelerator fund for early-stage life science companies in the lab phase focused on longevity and aging. Source: BioSpace
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer. Source: BioSpace
According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace
A federal judge has temporarily blocked the Trump administration's efforts to wind down DACA. Source: BioSpace
The move is part of the company’s strategy as it shifts from a consumer products company into a health tech company. Source: BioSpace